Purpose: Sacral root neuromodulation is becoming a superior alternative to the standard treatment of idiopathic nonobstructive urinary retention. We report results in 20 successive patients who underwent sacral foramen implantation to restore bladder function.
Idiopathic, nonobstructive chronic urinary retention is a perplexing entity in modern urological practice. Physicians do not usually have much to offer the patient except clean intermittent catheterization. Although this therapy represents a treatment breakthrough in this subcategory of patients, it is at the expense of quality of life and a high rate of urinary tract infection.
Sacral root neuromodulation was introduced in the mid 1980s as a revolutionary concept to regain bladder control in this difficult population.' Since then few studies have been published that address the efficacy and safety of this modalit^.^,^ We report the efficacy, safety and effect of sacral root neuromodulation in regard to quality of life in patients with idiopathic, nonobstructive chronic urinary retention.
MATERIALS AND METHODS
Included in our study were 19 women and 1 man 19.43 to 55.66 years old (mean age at presentation plus or minus standard error of mean 33.67 2 2.2) with a history of nonobstructive urinary retention 1.17 to 19 years (mean 5.23 rt_ 1.1) in duration. Patients were screened thoroughly to exclude obstructive or neurogenic etiologies. A detailed history was obtained and a clinical examination was performed. Baseline assessment included a comprehensive voiding diary for 4 successive days, SF-36 quality of life questionnaire, Beck depression inventory, uroflowmetry and urodynamic study. Patients then underwent screening percutaneous nerve evaluation to determine the response to sacral root neuromodulation. During this test wire electrodes were temporarily Accepted for publication October 3, 1997.
implanted percutaneously. Patients were sent home with a portable pulse generator and they were asked to complete another diary for at least 4 successive days while using stimulation. The details of the test have been described prev i o u~l y .~.~ A good response was defined as more than 50% improvement in voided volume and post-void residual catheterized urine.
Responders underwent implantation with a unilateral sacral foramen electrode connected to a n implanted pulse generator, as described previ~usly.'.~ They were then followed 1, 3 and 6 months after implantation, and every 6 months thereafter. Before each followup visit patients completed a 4-day diary, the Beck depression inventory and the SF-36 quality of life questionnaire. At each visit uroflowmetry was performed, any complications were reported and the implanted pulse generator was reprogrammed as necessary. At the 6-month followup visit patients underwent a urodynamic study. The generator was turned off until symptoms returned to baseline, when it was turned on.
The most important data extrapolated from the detailed diaries were voided and catheterized volume. Pelvic pain or discomfort was evaluated by a weighted score of 0 to 3. In addition, the degree of urgency before each void was also reported using a weighted score of 0-none to 3-severe.
Data are presented as mean plus or minus standard error of mean. Analysis of variance was used to compare data at different followup points. The Student t test was performed to compare data on urodynamics, the Beck depression inventory and the SF-36 quality of life questionnaire at baseline and 6 months aRer implantation in the 11 patients who completed this visit. Statistical significance was considered at p S0.05.
RESULTS
To date 20 patients with idiopathic nonobstructive chronic urinary retention have undergone implantation, and all have had at least 50% improvement in voided and post-void residual volume on percutaneous nerve evaluation screening. Mean followup was 15.17 months (range 1 to 74). Data on 2 patients who were lost to followup are not included in our study ( fig. 1) .
Baseline evaluation showed that none of our patients had detectable neurogenic or obstructive etiologies. Nine patients were in complete urinary retention, while in the remainder 50 to 80% of the total urinary output was post-void residual urine. All patients depended on clean intermittent catheterization at presentation. No abnormality was revealed by the baseline evaluation except for the inability of some patients to control the pelvic floor musculature and/or tenderness at the site of the levator ani.
In patients who underwent implantation significant improvement in voided volume at all followup visits was associated with a significant decrease in post-void residual catheterized volume ( fig. 2) . Post-void residual urine decreased from 78.3 to 5.5 to 10.2% of total urinary output at the postoperative followup visits. Associated pelvic pain statistically significantly improved, decreasing from 1.92 to 0.75 to 0.82 points of weighted score at baseline, and 3 and 6 months, respectively. In patients with pure urinary retention there was a tendency toward increased urgency, while in those with associated urgency, frequency or urge incontinence there was a tendency toward a decrease in the severity of urgency. All patients reported subjective improvement in all symptoms, including the sensation of emptiness after voiding.
Uroflowmetry results were impressive, reflecting the tremendous improvement in symptomatology. Because most patients were not able to void in the uroflowmetry device at baseline, we report only postoperative data. Voided and postvoid residual volumes, and peak and mean flow rates became almost normal, which was statistically significant. Figure 3 and table 1 show the results of urodynamics at 6-month followup compared to those at baseline. No significant difference was noted in cystometrography data. Due to the inability of most patients to void preoperatively table 1 represents only the 6-month data of the pressure-flow studies, which are within normal limits.
The Beck depression inventory demonstrated almost 50% improvement after 6 months of implantation, although it did not reach statistical significance. The SF-36 quality of life questionnaire revealed improvement in almost all items but only the question on "general health change in the last year" was statistically significant. Table 2 shows the comparison of baseline and 6-month followup data. Complications were minimal and within our expectations, and none was life threatening. They included implant failure and subsequent replacement of the implanted pulse generator in 1 patient, battery failure after 4 to 6 years of continuous use and replacement in 2, implant infection leading to explantation and reimplantation 6 weeks later in 1, electrode migration in 2, pain at the implant site that was relieved by changing the site of the implanted pulse generator in 2, and superficial wound infection and dehiscence that healed properly in less than 4 weeks in 2.
In addition, the data obtained by percutaneous nerve evaluation are reliable, as demonstrated by reproducibility at followup. Voided and post-void residual urine volumes were comparable among diary entries at the followup visits. Urinary tract infections decreased from 10.2 -C 2.62 to 3.6 2 1.4 per patient yearly. All symptoms returned to baseline levels 2 days to 6 weeks aRer the stimulator was turned off a t the 6-month followup visit, or when the implant or battery failed. Most patients used the stimulators 24 hours daily, 3 reported better flow when they turned the stimulator off during voiding and 1 turned the stimulator on only at the time of voiding. Unfortunately few studies on this subject have been published and most included a small number of patients followed for a short period.'^^,^ We present data on 20 patients with chronic nonobstructive urinary retention who underwent implantation. Our current results parallel our preliminary results but this series includes a much larger number of patients and longer followup.2 Our current findings support those of Vapnek and Schmidt: and Thon et a1 ?
We observed notable improvement in the voiding behavior of all patients. Bladder control was restored in all who underwent implantation, which was also demonstrated by the normalization of uroflowmetry and pressure-flow study data postoperatively. Followup shows that this improvement tends to persist in the long term. Alleviation of the need for clean intermittent catheterization in these patients had a direct impact on quality of life, as revealed by improvement in certain items of the SF-36 quality of life questionnaire and Beck depression inventory. We believe that statistical significance would be reached by increasing the sample size and using disease specific quality of life questionnaires. Implantation also led to the significantly decreased infection rate. Another factor with a substantial impact on patient quality of life is the significant improvement in associated pelvic pain. Furthermore, the procedure does not result in high morbidity and it has a low complication rate, which makes it appealing in this population. The reproducibility of the results of percutaneous nerve evaluation in these patients after implantation shows that this procedure is suitable for use as a screening test. We believe that percutaneous nerve evaluation represents a milestone in the optimization of this procedure by providing the patient and treating physician an opportunity to foresee the outcome of implantation.
The mechanism by which neuromodulation restores bladder function in chronic nonvoiders is not clearly understood. In our previous and current studies we noted that most patients in retention lack pelvic floor control.2 Schmidt believed that neuromodulation may function through directing the patient to relocalize the pelvic floor and, hence, regain the capability of relaxing it and initiating voiding? This hypothesis is supported by the observation that 1 patient in our series required stimulation only during voiding. It is further supported by the inability of most patients to void if they no longer feel the stimulation for some reason. Detrusor contraction through direct stimulation of the autonomic efferents cannot explain this improvement in patients in retention because electrostimulation to induce voiding requires much higher current than that used in our patients, in addition to the dyssynergic voiding that occurs due to simultaneous contraction of the sphincter secondary to activation of the somatic efferents.' Vapnek and Schmidt theorized that there is over inhibition of the voiding reflex through a certain pathological reflex, which becomes inhibited by neural stimulation.' This theory is based on the observation of the inability of these patients to localize the pelvic floor. Neuromodulation increases patient awareness of this area, enabling them to relax it to initiate voiding.
We agree that there is over inhibition of the voiding reflex by a certain pathological reflex involving the pelvic floor. However, we believe that sacral root neural stimulation causes long-term neuronal modulation through afferent input to the spinal cord, inhibiting this pathological reflex. This chronic neuromodulation persists for a variable period after stimulation ceases. This hypothesis is supported by the study of Wall, who presented the enhanced afference the01-y.~ He demonstrated that the response threshold of a certain nerve may be lowered by a chronic noxious stimulus, such as chronic strain, which may result in increased aberrant feedback to the spinal cord in the long term. In turn, this condition may cause a state of spastic reflexes or inhibition of behavior. The fact that there was no difference in cystometrography results preoperatively and postoperatively indicates that the origin of the problem is not the bladder, but the pelvic floor musculature.
CONCLUSIONS
We believe that our series supports the role of sacral root neuromodulation as a treatment alternative in patients with idiopathic, nonobstructive chronic urinary retention. All such patients should undergo percutaneous nerve evaluation before implantation is attempted. The consistent results, and low morbidity and complication rate of this procedure makes it a suitable choice in this patient population. We think that intensive basic research on the molecular level is needed to understand the mechanism of action of neuromodulation.
